Skip to main content

Poster Presentations

BEHAVIORAL SCIENCE AND VACCINE HESITANCY

American College of Obstetricians and Gynecologists: Quantitative and Qualitative Evaluation of Pregnant Women’s Attitudes and Behaviors Related to Vaccination During Pregnancy
Sarah S. Wright, MA
Senior Program Manager, Immunization, Infectious Disease, and Public Health Preparedness, American College of Obstetricians and Gynecologists (ACOG), Washington, DC

Development and Evaluation of an Educational Human Papillomavirus (HPV) Vaccine Comic Book for College Students in Northeast Ohio: An Application of the Integrative Behavior Model
Obianuju G. Aguolu, PhD, MPH, MBBS
Postdoctoral Associate, Yale University, New Haven, CT

Increasing Vaccine Compliance Among College Freshmen
Kimberly Stevenson, RN, BSN
Cancer & Transplant Nurse, Intermountain Healthcare, Alpine, UT

Trends in the Uptake of Pediatric Measles-Containing Vaccine in the United States: A Disneyland Effect?
Margaret K. Doll, PhD, MPH
Assistant Professor, Department of Population Health Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY


EPIDEMIOLOGY AND BURDEN OF VACCINE-PREVENTABLE DISEASES

Epidemiology of Seasonal Influenza and Benefit of Influenza Vaccination Among the Elderly in Japan: A Systematic Literature Review and Meta-Analysis
Kiyosu Taniguchi, MD, PhD
Director, Department of Cllinical Research, National Mie Hospital, Tsu City, Mie Prefecture, Japan

Influenza Vaccine Effectiveness Among Outpatients in the US Influenza Vaccine Effectiveness Network by Study Site 2011–2016
Richard K. Zimmerman, MD, MPH
Professor, University of Pittsburgh, Pittsburgh PA

Measuring Population Immunity to Measles in Canada Using Canadian Health Measures Survey Data
Selma Osman, MPH, HBSc
Research Coordinator, Public Health Ontario, Toronto, Ontario, Canada

Respiratory Viral Infection Surveillance in Pediatric Hematopoietic Stem Cell Transplant Recipients
Lubna Hamdan, MD
Postdoctoral Fellow, Vanderbilt University Medical Center, Nashville, TN

Systematic Review of Diagnostic Accuracy of Dried Blood Spots for Diagnosis and Seroprevalence of Vaccine-Preventable Diseases
Taylor A. Holroyd, MSPH
Doctoral Student, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

VACCINE POLICY, PROGRAMS, AND PRACTICE

Association Between Vaccine Exemption Policy Change in California and Increased Parental Adverse Event Reporting
Anne M. Hause, PhD, MSPH
Vaccinology Fellow, Emory University; Centers for Disease Control and Prevention, Atlanta, GA

Completion of Two-Dose Recombinant Zoster Vaccine Series in Adults 50 Years and Older
Bradley Ackerson, MD
Co-Investigator, Kaiser Permanente Southern California, Pasadena, CA

Consideration of Effective Seroprotection Rate and Cost Per Protected Patient as Estimates of Real-World Outcomes in Adult Hepatitis B Virus (HBV) Vaccination
Randall N. Hyer, MD, PhD, MPH
Vice President, Clinical Development and Medical Affairs, Dynavax Technologies Corporation, Emeryville, CA

Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Prevention in Mali
Rachel S. Laufer, MPH
Student, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD

El Paso’s Health Department Strategies Improve HPV Vaccination Rates Among Adolescents
Claudia S. Lozano, MPH, CHES
Medicaid Waiver Program Manager, City of El Paso Department of Public Health, El Paso, TX

Immunogenicity of Twice-Annual Influenza Vaccination in Older Adults in Hong Kong: A Randomized Controlled Trial
Nancy H. L. Leung, PhD, MPhil
World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China

Impact of the New York State Repeal of Nonmedical Vaccination Exemptions on Schools: Perspectives from a Survey of School Administrators
Margaret K. Doll, PhD, MPH
Assistant Professor, Department of Population Health Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY

Potential Public Health Impact in the US of a MenABCWY Vaccine Targeting Neisseria meningitidis Serogroups A, B, C, W and Y
Liping Huang, MD, MA, MS
Director, Global Health Economics and Outcomes Research, Patient Health & Impact, Pfizer Inc., Collegeville, PA

Understanding Patient Preferences for Meningococcal Serogroup B Vaccines
Liping Huang, MD, MA, MS
Director, Global Health Economics and Outcomes Research, Patient Health & Impact, Pfizer Inc., Collegeville, PA

Preventing Acute Rises in Hepatitis B Within the Opioid Epidemic: Policy and Primary Care Practice-Based Opportunities to Increase Adult Hepatitis B Vaccination in the United States
Rita K. Kuwahara, MD, MIH
Internal Medicine Resident Physician, Connecticut Institute for Communities, Inc., Danbury, CT

Relative Effectiveness of aTIV versus TIV and HD-TIV Against Influenza-Like Illness in the US During the 2017–2018 and 2018–2019 Influenza Seasons
Constantina Boikos, PhD, MSPH
Senior Manager, Center for Outcomes Research & Evaluation, Seqirus, Montreal, Quebec


VACCINE RESEARCH, DEVELOPMENT, AND PRODUCTION

A Prime-Boost Concept Using a T Cell Epitope-Driven DNA Vaccine Followed by a Whole Virus Vaccine Effectively Protected Pigs in the Pandemic H1N1 Pig Challenge Model
Lenny Moise, PhD
Director of Vaccine Research, EpiVax Inc., Providence, RI

Antibody Responses Against Heterologous H5N1 Strains for an MF59-Adjuvanted Cell Culture-Derived H5N1 (aH5N1c) Influenza Vaccine
Esther Van Twuijver, PhD
Senior Clinical Scientist, Seqirus, Amsterdam, Netherlands

Immunogenicity, Lot-to-Lot Consistency, and Safety of an MF59-Adjuvanted Cell Culture-derived H5N1 (aH5N1c) Influenza Vaccine in Healthy Adults
Esther Van Twuijver, PhD
Senior Clinical Scientist, Seqirus, Amsterdam, Netherlands

Antigenicity and Protective Efficacy of a Virus Like Particle (VLP) Vaccine Against Zika Virus
Gregory Ruddy
Graduate Student, Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, El Paso, TX

Burkholderia pseudomallei Induces Regulatory T Cell Responses: Implications for Improving Vaccine Design Through the Identification of Human-Like T Cell Epitopes
Lauren Meyers, PhD
Postdoctoral Research Fellow, EpiVax Inc., Providence, RI

Durability and Limited Cross-Protection of Live Oral Adenovirus Vaccines
Natalie Collins, PhD
Chief of Diagnostic and Clinical Readouts, Walter Reed Army Institute of Research, Silver Spring, MD

Efficacy and Safety of a Booster Dose of the MenACWY-TT Vaccine Administered 10 Years After Primary Vaccination with MenACWY-TT or MenACWY-PS
Paula Peyrani, MD
Associate Director, Pfizer Inc., Collegeville, PA

Francisella tularensis Live Vaccine Strain (LVS) Effects on Innate Immune Memory
Hamda Khan, MHS
ORISE Fellow, US Food and Drug Administration, Silver Spring, MD

In vivo Adjuvant Activity of Small Molecule Mast Cell Activators Identified by High-Throughput Screening
Brandi T. Johnson-Weaver, PhD
Research Scientist, Duke University Medical Center, Durham, NC

Mucosal Correlates of Protection After Influenza Viral Challenge of Vaccinated and Unvaccinated Healthy Volunteers
Rachel M. Bean, MD
Senior Research Fellow, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD

Norovirus Neutralization in Human Intestinal Enteroids Reveals Complex Antigenic Relationships Between and Within Genotypes
Lauren A. Ford-Siltz, PhD
Staff Fellow, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD

Preclinical Evaluation of cGLP Grade Leishmania donovani Centrin Gene Deleted Live Attenuated Parasite Vaccine
Angamuthu Selvapandiyan, PhD
JH-Institute of Molecular Medicine, Jamia Hamdard, New Delhi, India

Predicting Vaccine Efficacy Against Mycobacterium tuberculosis with a Functional Correlate of Protection, an In Vitro Co-Culture Assay Using Alveolar Macrophages
Chelsea C. Lehman, MPH
Oak Ridge Institute for Science and Education (ORISE) Fellow, US Food and Drug Administration, Silver Spring, MD


VACCINE SAFETY AND MONITORING

Myopericarditis After Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990–2018
John R. Su, MD, PhD, MPH
Medical Officer, Centers for Disease Control and Prevention, Atlanta, GA

Primary Ovarian Insufficiency After Vaccination: Reports to the Vaccine Adverse Event Reporting System
Patricia Wodi, MD
Public Health Physician, Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA

Safety of Excess Doses of Vaccine: Reports from the Vaccine Adverse Event Reporting System (VAERS), 2007–2017
Pedro L. Moro, MD, MPH
Medical Epidemiologist, Centers for Disease Control and Prevention, Atlanta, GA

Surveillance of Vaccine Adverse Events in Pregnant Women Reported to the Vaccine Adverse Events Reporting System (2010–2019)
Salena Marie Preciado, MS
Graduate Student, Chapman University School of Pharmacy, Irvine, CA


VACCINES AGAINST EMERGING AND RE-EMERGING INFECTIOUS DISEASES

Accuracy and Efficacy of Dengue CYD-TDV Pre-Vaccination Screening with Five Existing IgG Serotests: Retrospective Analysis of Phase III Trials
Stephen J. Savarino, MD, MPH
Associate Vice President, New Translational Sciences and Biomarkers, Sanofi Pasteur, Swiftwater, PA

Comprehensive Antigenic Mapping Reveals Changes in B Cell Immunodominance as Additional Mechanism for Emergence of New GII.4 Noroviruses
Kentaro Tohma, PhD
Postdoctoral Fellow, US Food and Drug Administration, Silver Spring, MD

As of 02/24/2020